Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 12,327 | N/A |
| Marketable Securities | 0 | 0 | 0 | 7,323 | N/A |
| Other current assets | 0 | 0 | 0 | 2,574 | 4,810 |
| TOTAL | $0 | $0 | $0 | $22,224 | $4,810 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 1,230 | N/A |
| Other Non-Current Assets | 0 | 0 | 0 | 719 | 1,170 |
| TOTAL | $N/A | $N/A | $N/A | $1,949 | $1,170 |
| Total Assets | $0 | $0 | $0 | $23,904 | $5,980 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 1,636 | 4,430 |
| Accrued Expenses | 0 | 0 | 0 | 3,314 | 8,730 |
| Other current liabilities | 0 | 0 | 0 | 0 | 9,350 |
| TOTAL | $0 | $0 | $0 | $4,950 | $22,510 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 156 | 157 | 205 | 345 | 160 |
| TOTAL | $N/A | $N/A | $N/A | $630 | $5,230 |
| Total Liabilities | $0 | $0 | $0 | $5,580 | $27,740 |
| Shareholders' Equity | |||||
| Common Shares | 0 | 0 | 0 | 0 | 70 |
| Retained earnings | 0 | 0 | 0 | -91,862 | N/A |
| Other shareholders' equity | 0 | 0 | 0 | 110,186 | -2,350 |
| TOTAL | $0 | $0 | $0 | $18,324 | $1,086,350 |
| Total Liabilities And Equity | $0 | $0 | $0 | $23,904 | $1,114,090 |